HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine.
Yu Z, Liu W, He Y, Sun M, Yu J, Jiao X, Han Q, Tang H, Zhang B, Xian Y, Qi J, Gong J, Xin W, Shi G, Shan F, Zhang R, Li J, Wei M.
Yu Z, et al. Among authors: shan f.
J Hematol Oncol. 2021 Apr 28;14(1):71. doi: 10.1186/s13045-021-01081-7.
J Hematol Oncol. 2021.
PMID: 33910591
Free PMC article.